Table 3. Multivariable Regression Models Predicting Global Neurocognitive Impairmenta.
Parameters | Global Neurocognitive Impairmentb | |
---|---|---|
RR (95% CI) | P Value | |
Propofol, per 100 mg/kg | 1.40 (1.11-1.75) | .004 |
Fentanyl, per 10 μg/kg | 1.20 (0.99-1.45) | .07 |
Midazolam hydrochloride, per 1 mg/kg | 1.07 (0.42-2.73) | .89 |
Meperidine hydrochloride, per 1 mg/kg | 0.98 (0.93-1.04) | .47 |
Morphine sulfate, per 1 mg/kg | 0.70 (0.28-1.70) | .43 |
Pentobarbital sodium, per 10 mg/kg | 1.02 (0.90-1.15) | .74 |
Glycopyrrolate, per 1 μg/kg | 1.00 (1.00-1.01) | .14 |
Fluranes (per exposure)c | 1.10 (1.01-1.21) | .03 |
Duration (per h) | 1.03 (1.00-1.06) | .04 |
Abbreviation: RR, relative risk.
Models are adjusted for age at diagnosis, sex, total intrathecal chemotherapy count, and cumulative dose of high-dose intravenous methotrexate.
Global neurocognitive impairment is defined as 3 or more tests falling more than 2 standard deviations below the age-adjusted population normative means.
Number of exposures was identified for fluranes because cumulative dose cannot be accurately captured for inhaled anesthetic agents.